LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel
(NasdaqGM:LBRX), NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals, Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases, today announced the appointment Dr. Minako Pazdera as General Counsel. Dr. Pazdera joins LB Pharmaceuticals with more than 25 years of […]